Lipid metabolism: the potential targets for toxoplasmosis treatment
Abstract Toxoplasmosis is a zoonosis caused by Toxoplasma gondii (T. gondii). The current treatment for toxoplasmosis remains constrained due to the absence of pharmaceutical interventions. Thus, the pursuit of more efficient targets is of great importance. Lipid metabolism in T. gondii, including f...
Main Authors: | Tian-Yi He, Ye-Tian Li, Zhen-Di Liu, Hao Cheng, Yi-Feng Bao, Ji-Li Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | Parasites & Vectors |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13071-024-06213-9 |
Similar Items
-
Toxoplasmosis during pregnancy and infancy
by: René Stricker, et al.
Published: (2009-10-01) -
SEROPREVALENCE OF HUMAN TOXOPLASMOSIS IN KALLARWALI, MUZAFFAR GARH, PAKISTAN
by: Sikandar Hayat, et al.
Published: (2015-01-01) -
Valutazione pilota di un sistema automatico per lo screening anticorpale della toxoplasmosi
by: Pietro Casella, et al.
Published: (2005-12-01) -
Management of the Toxoplasmosis in Pregnancy: Knowledge and Attitude of Physicians
by: Gül Ruhsar YILMAZ, et al.
Published: (2017-09-01) -
In vitro Evaluation of Mannosylated Paromomycin-Loaded Solid Lipid Nanoparticles on Acute Toxoplasmosis
by: Mojdeh Khosravi, et al.
Published: (2020-02-01)